These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 1409411)
21. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism. Matsunaga J; Dakeishi M; Miyamura Y; Tomita Y Pigment Cell Res; 1997; 10(1-2):64-7. PubMed ID: 9170165 [TBL] [Abstract][Full Text] [Related]
22. Non-random distribution of missense mutations within the human tyrosinase gene in type I (tyrosinase-related) oculocutaneous albinism. King RA; Mentink MM; Oetting WS Mol Biol Med; 1991 Feb; 8(1):19-29. PubMed ID: 1943686 [TBL] [Abstract][Full Text] [Related]
23. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism. King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307 [TBL] [Abstract][Full Text] [Related]
24. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism. Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634 [TBL] [Abstract][Full Text] [Related]
25. The shift from physiological genetics to molecular genetics in the study of mouse tyrosinase. Quevedo WC; Holstein TJ Pigment Cell Res; 1992; Suppl 2():57-60. PubMed ID: 1409439 [No Abstract] [Full Text] [Related]
26. Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism. Oetting WS; Handoko HY; Mentink MM; Paller AS; White JG; King RA J Invest Dermatol; 1991 Jul; 97(1):15-9. PubMed ID: 1676041 [TBL] [Abstract][Full Text] [Related]
27. The tyrosinase-positive oculocutaneous albinism locus maps to chromosome 15q11.2-q12. Ramsay M; Colman MA; Stevens G; Zwane E; Kromberg J; Farrall M; Jenkins T Am J Hum Genet; 1992 Oct; 51(4):879-84. PubMed ID: 1415228 [TBL] [Abstract][Full Text] [Related]
28. OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene. Chaki M; Sengupta M; Mukhopadhyay A; Subba Rao I; Majumder PP; Das M; Samanta S; Ray K Ann Hum Genet; 2006 Sep; 70(Pt 5):623-30. PubMed ID: 16907708 [TBL] [Abstract][Full Text] [Related]
29. The clinical spectrum of albinism in humans. Oetting WS; Brilliant MH; King RA Mol Med Today; 1996 Aug; 2(8):330-5. PubMed ID: 8796918 [TBL] [Abstract][Full Text] [Related]
30. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism. Shimizu H Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668 [TBL] [Abstract][Full Text] [Related]
31. The pink-eyed dilution gene and the molecular pathogenesis of tyrosinase-positive albinism (OCA2). Manga P; Orlow SJ J Dermatol; 1999 Nov; 26(11):738-47. PubMed ID: 10635616 [No Abstract] [Full Text] [Related]
32. One-allele system in the Korean for MboI-RFLP in exon 1 of the human tyrosinase (TYR) gene. Kim DK; Kang KH; Choi IJ J Dermatol Sci; 2000 Sep; 24(1):1-3. PubMed ID: 10960773 [TBL] [Abstract][Full Text] [Related]
33. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism. Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321 [TBL] [Abstract][Full Text] [Related]